UTHR

MKT CAP:$23B

United Therapeutics Corporation

Market Cap

$23B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$544.69+$47.97 (+9.66%)

Jun 8, 2026

52W High $596.7652W Low $274.70

Company Details

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvas...

CEO

—

IPO Date

Jun 17, 1999

Website

www.unither.com

Key Metrics TTM

Revenue

$3.2B

+5.9% YoY

Net Income

$1.3B

EPS (Diluted)

Free Cash Flow

$1.0B

Revenue / Share

$67.16

Gross Margin

86.6%

Operating Margin

45.3%

Net Margin

40.6%

FCF Margin

32.1%

P/S

7.2x

P/E

17.8x

Earnings Reports

Q2 2026

Jul 29, 2026

PENDING

Q1 2026

May 6, 2026

$782M-1.6%

FY 2025

Feb 25, 2026

$3.2B+10.6%

Q4 2025

Feb 25, 2026

$790M+7.4%

Q3 2025

Oct 29, 2025

$800M+6.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee